• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

From clinical trials to real-world practice: Immune checkpoint inhibitors in older adults.

作者信息

Loh Kah Poh, Wong Melisa L, Maggiore Ronald

机构信息

Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.

Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.

出版信息

J Geriatr Oncol. 2019 May;10(3):384-388. doi: 10.1016/j.jgo.2019.01.023. Epub 2019 Feb 8.

DOI:10.1016/j.jgo.2019.01.023
PMID:30745116
Abstract
摘要

相似文献

1
From clinical trials to real-world practice: Immune checkpoint inhibitors in older adults.从临床试验到实际应用：老年患者中的免疫检查点抑制剂
J Geriatr Oncol. 2019 May;10(3):384-388. doi: 10.1016/j.jgo.2019.01.023. Epub 2019 Feb 8.
2
Optimal design and endpoint of clinical trials using immune checkpoint blocking agents.使用免疫检查点阻断剂的临床试验的优化设计与终点
Expert Rev Anticancer Ther. 2016 Dec;16(12):1217-1218. doi: 10.1080/14737140.2016.1248945. Epub 2016 Oct 28.
3
Real-world use and survival outcomes of immune checkpoint inhibitors in older adults with non-small cell lung cancer.免疫检查点抑制剂在老年非小细胞肺癌患者中的真实世界应用和生存结局。
Cancer. 2020 Mar 1;126(5):978-985. doi: 10.1002/cncr.32624. Epub 2020 Jan 14.
4
Immunotherapy in Older Adults with Cancer.癌症老年患者的免疫治疗。
Curr Oncol Rep. 2019 May 7;21(7):56. doi: 10.1007/s11912-019-0806-2.
5
Older and younger patients treated with immune checkpoint inhibitors have similar outcomes in real-life setting.在真实环境中，接受免疫检查点抑制剂治疗的老年和年轻患者具有相似的结局。
Eur J Cancer. 2019 Nov;121:192-201. doi: 10.1016/j.ejca.2019.08.027. Epub 2019 Oct 4.
6
Efficacy of immune checkpoint inhibitors in cancer patients of different ages: a meta-analysis.免疫检查点抑制剂在不同年龄癌症患者中的疗效：一项荟萃分析。
Future Oncol. 2019 Nov;15(31):3633-3646. doi: 10.2217/fon-2019-0279. Epub 2019 Oct 25.
7
[Checkpoint inhibitors, the perspectives for elderly patients].[检查点抑制剂，老年患者的前景]
Soins Gerontol. 2017 Sep-Oct;22(127):30-33. doi: 10.1016/j.sger.2017.06.010.
8
[The role of immune checkpoint inhibitors in lung cancer: from clinical trials to clinical practice].[免疫检查点抑制剂在肺癌中的作用：从临床试验到临床实践]
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 12;43(2):95-99. doi: 10.3760/cma.j.issn.1001-0939.2020.02.006.
9
Comparison of Solid Tumor Treatment Response Observed in Clinical Practice With Response Reported in Clinical Trials.比较临床实践中观察到的实体瘤治疗反应与临床试验中报告的反应。
JAMA Netw Open. 2021 Feb 1;4(2):e2036741. doi: 10.1001/jamanetworkopen.2020.36741.
10
Efficacy and Adverse Events of Immunotherapy with Checkpoint Inhibitors in Older Patients with Cancer.免疫检查点抑制剂在老年癌症患者中的疗效和不良反应。
Drugs Aging. 2019 Oct;36(10):927-938. doi: 10.1007/s40266-019-00697-2.

引用本文的文献

1
Safety and tolerability of PD-1/PD-L1 inhibitors in elderly and frail patients with advanced malignancies.程序性死亡蛋白1/程序性死亡配体1抑制剂在老年和体弱晚期恶性肿瘤患者中的安全性和耐受性。
Oncol Lett. 2020 Oct;20(4):14. doi: 10.3892/ol.2020.11875. Epub 2020 Jul 15.
2
Geriatric oncology research at the 2019 American Geriatrics Society (AGS) annual meeting: Joint perspectives from the Young International Society of Geriatric Oncology (SIOG) and AGS Cancer and Aging Special Interest Group.2019年美国老年医学会（AGS）年会中的老年肿瘤学研究：国际老年肿瘤学青年学会（SIOG）与AGS癌症与衰老特别兴趣小组的联合观点
J Geriatr Oncol. 2019 Nov;10(6):994-997. doi: 10.1016/j.jgo.2019.06.008. Epub 2019 Jul 1.
3
Geriatric assessment and treatment outcomes in older adults with cancer receiving immune checkpoint inhibitors.
接受免疫检查点抑制剂治疗的老年癌症患者的老年评估与治疗结果
J Geriatr Oncol. 2020 Apr;11(3):523-528. doi: 10.1016/j.jgo.2019.05.021. Epub 2019 Jun 4.